Coagulation Analyzers Market: Industry Analysis and Forecast (2024-2030) Trends, Statistics, Dynamics, Segmentation by Product, Testing type, End User and Region

Coagulation Analyzers Market Overview:

The blood clotting capability of anybody can be determined by various tests such as PT, ACT, APTT which can be performed with the help of coagulation analyzers.  At present the global market for coagulation analyzers is projected to reach a value of 5.94 billion USD in 2030 from a value of 3.57 billion USD in 2023. The coagulation analyzers market is set to keep growing due to increase in the type of lifestyle diseases as well. The segmentation for coagulation market analyzers is done on the basis of testing type, technology, end-user and product type. Region-wise segmentation of the market includes North America, Europe, Asia-Pacific, Middle East & Africa along with South America.  

 

 

To get more Insights: Request Free Sample Report

 

Coagulation Analyzers Market Dynamics:

The overall global coagulation analyzers market is driven by the increasing population of patients with chronic blood disorders and increasing geriatric population that requires help with the coagulation issue. The number of people suffering from bleeding disorders is huge, as per a report from World Hemophilia Federation issued in Annual Global Survey 2020 a total of 3,47,026 people were suffering from bleeding disorder. The demand for coagulation analyzers will keep increasing in future owing to the ever-increasing number of people that are projected to suffer from bleeding disorders. As per an update from International Society on Thrombosis and Haemostasis in 2022 every year approximately 10 million cases of venous thromboembolism arise. Moreover, in Europe alone deaths related to deep vein thrombosis is around 5,44,000 annually. All these factors indicate the increasing demand for coagulation analyzers which will further boost the coagulation analyzers market. Coagulation analyzers are in high demand right now because of increase in blood disorders and lifestyle conditions. A micro-coagulant system is used in hemostasis/coagulation analyzers to measure and evaluate the speed of clot formation or blood coagulation. The device reduces the risk of heart attacks, thrombosis, and embolism by detecting blood clots in the blood vessels. In few minutes the user can measure the thromboplastin levels coagulation pathway speed using a hemostasis/coagulation analyzer. This method is based on the optical detection principle, which detects changes in light intensity induced by dispersed light during blood coagulation.

 

The impact of COVID-19 has been huge on the coagulation analyzers market. Hematology analyzers can provide information on hemoglobin in red blood cells (RBCs), corpuscular data, platelet counts, and hematocrit levels in most cases. New devices, however, have been created to assess two specialized cell types: nucleated RBCs and immature white cells. Modern complex coagulators are also known for their high throughput, versatility, and dependability. Aside from that, they offer increased accuracy and precision, as well as simple-to-use complex software with built-in graphs and calibration curves. Furthermore, the prevalence of cardiac diseases and blood disorders has increased significantly, necessitating the development of enhanced coagulation analyzers around the world. Aside from that, the growing number of hospitals, diagnostic centers, and research institutes around the world has a beneficial impact on coagulation analyzer sales.

 

Coagulation Analyzers Market Segment Analysis:

On the basis of testing type, the coagulation analyzers market can be further classified into Fibrinogen Testing, D Dimer Testing, Platelet function tests, Prothrombin time testing and other coagulation tests. Amongst the testing type segment Prothrombic time testing has the largest share in the market and is also the fastest growing one. One of the major reasons for the market dominance of Prothrombin time testing method is due to the fact that lot of laboratories

 

The coagulation analyzers market is classified into different segments by technology used which includes Optical technology, mechanical technology, electrochemical technology and other techniques. Amongst the technology type segment optical segment has the largest market share and also happens to be the fastest growing segment due to the high performance. The test results arrived by using optical technology are more accurate than other techniques. Moreover, optical technology analyzers have multipurpose use and can be used in combination with immunological and chromogenic techniques.

 

On the basis of end-user, coagulation analyzers market can be further segmented into hospitals, diagnostic centres and others. Amongst the end user categorisation diagnostic centres have the highest share in the coagulation analyzers market globally. This is largely due to the practice of outsourcing tests by hospitals which enables diagnostics centres to hold the largest share amongst other end-users.

 

On the basis of product, the coagulation analyzers market is segmented into analyzers and consumables. Analyzers are utilised in laboratories however consumables are further segmented into strains and reagents. All tests require reagents and hence result in repeat orders as they get consumed for tests and for this primary reason consumables hold majority market share.

 

Coagulation Analyzers Market Regional Insights:

North America is expected to dominate the market share of coagulation Analyzers globally. Within the North American region, USA is expected to have the largest share in the Analyzers market owing to the increasing prevalence of chronic blood disorders.

 

The European market is expected to be the second largest market globally during the mentioned forecast period. A number of factors drive the growth of coagulation analyzers market in Europe some of them being growing ageing population, year on year growth of incidences in chronic blood diseases amongst the population. The German market is projected to have the dominant share in the European region.

 

Asia-Pacific market is projected to be the fastest growing market amongst all other markets globally during the forecast period. As more countries in the Asia-Pacific region are becoming technologically advanced the need to coagulation analyzers has been increasing ever since. Additionally with heavily populated countries like China and India in the region the market is expected to increase in size owing to the economic development and prosperity.

 

ME&A region is expected to have a sluggish growth rate during the forecast period. The South American market is projected to have a relatively decent growth rate during the forecast period as healthcare infrastructure is growing by leaps and bounds in that region.

 

The objective of the report is to present a comprehensive analysis of the Coagulation Analyzers market to the stakeholders in the industry. The report provides trends that are most dominant in the Coagulation Analyzers market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the Coagulation Analyzers Market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

 

The qualitative and quantitative data provided in the Coagulation Analyzers market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Coagulation Analyzers market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the Coagulation Analyzers market.

 

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals exist, who they are, and how their product quality is in the Coagulation Analyzers market. The report also analyses if the Coagulation Analyzers market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly, if the market is dominated by a few players, etc.

 

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Coagulation Analyzers market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Coagulation Analyzers market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Coagulation Analyzers market is aided by legal factors.

 

Coagulation Analyzers Market Scope:

Coagulation Analyzers Market
Market Size in 2023	USD 4.59 Bn.
Market Size in 2030	USD 8.31 Bn.
CAGR (2024-2030)	8.85%
Historic Data	2018-2022
Base Year	2023
Forecast Period	2024-2030
Segment Scope	by Testing Type Fibrinogen Testing D Dimer Testing Platelet function tests Other coagulation tests
	by Technology Optical Technology Mechanical Technology Electrochemical Technology Others
	By End User Hospitals Diagnostic Centers Others
	by Product Analyzers Consumables
Regional Scope	North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America

 

Coagulation Analyzers Market Key Players

• Abbott Laboratories (US)
• Danaher (US)
• Siemens Healthineers Group (Germany)
• Sysmex Group (US)
• Thermo Fisher Scientific (US)
• Horiba (Japan)
• Nihon Kohden (Japan)
• Roche Diagnostics (Switzerland)
• Maccura Biotechnology Co. Ltd. (China)
• Bio Group Medical System (Italy)
• A&T Corporation (Japan)
• Beijing Succeeder Technology Inc. (China)
• Diagnostica Stago SAS (France)
• Helena Laboratories (US) Key Player 14
• Eurolyser (Austria)